GlaxoSmithKline statement in response to FDA announcement on TIDE trial
- Details
- Category: GlaxoSmithKline
GlaxoSmithKline [NYSE: GSK] confirmed that it will suspend enrollment of new patients in the Thiazolidinedione Intervention with Vitamin D Evaluation (TIDE) clinical trial at the request of the U.S. Food and Drug Administration (FDA) pending FDA review of recommendations from its Advisory Committee meeting July 13-14.
Abbott Reports Strong Second Quarter Results
- Details
- Category: Abbott
Abbott (NYSE: ABT) today announced financial results for the second quarter ended June 30, 2010.
Novartis delivers strong financial performance in second quarter
- Details
- Category: Novartis
Novartis delivered a strong performance in the second quarter of 2010 - with the rapid expansion of recently launched products and important regulatory approvals achieved for new medicines - as the Group made progress on its agenda on innovation, growth and productivity.
Bayer Schering Pharma enters strategic partnership with Hospital in China
- Details
- Category: Bayer
Bayer Schering Pharma AG, Germany, has entered into a research collaboration agreement with The People's Liberation Army General Hospital (301 Hospital) in Beijing, China.
FDA Grants Priority Review Designation to Denosumab
- Details
- Category: Amgen
Amgen (Nasdaq: AMGN) announced that the U.S. Food and Drug Administration (FDA) has granted priority review designation to denosumab, a subcutaneous RANK Ligand inhibitor, for the treatment of bone metastases to reduce skeletal related events (SREs) in patients with cancer.
Mylan to Acquire Bioniche Pharma Global Injectable Pharmaceuticals Business
- Details
- Category: Financial
Mylan Inc. (Nasdaq: MYL) has announced plans to acquire Bioniche Pharma Holdings Limited, a privately held, global injectable pharmaceutical company for $550 million in cash.
Amgen Foundation and Changemakers Launch Global Online Competition to Empower Patients
- Details
- Category: Amgen
The Amgen Foundation is supporting an online competition with Ashoka's Changemakers to find the best solutions that elevate patients' voices to improve health outcomes globally.
More Pharma News ...
- GlaxoSmithKline (GSK) responds to Senate Finance Committee letter
- Pfizer Strengthens Manufacturing Capabilities in Asia
- Data support Avandia (rosiglitazone maleate) cardiovascular safety profile
- Testing for Human Papillomavirus Genotypes 16 and 18 Detects Cervical Pre-Cancer Missed by Pap Test
- Lilly to Acquire Alnara Pharmaceuticals
- Nycomed's Daxas® (roflumilast) receives marketing authorisation in the European Union
- AstraZeneca and MRC Technology Form Strategic Alliance in Discovery Research